Pregabalin: Difference between revisions
>Utaninja m It has been approved in a later part of the wiki with studies that Pregabalin has seizure concerns. This mark is no longer needed. |
>Utaninja This is a duplicate study. I am uncertain if this is accidental or if the user that accepted my edit meant to include a different study. |
||
Line 163: | Line 163: | ||
===Seizure Risk=== | ===Seizure Risk=== | ||
Pregabalin has been shown to induce and or increase the risk of seizures at recreational dosages.<ref>https://doi.org/10.1101/cshperspect.a022863 | Pregabalin has been shown to induce and or increase the risk of seizures at recreational dosages.<ref>https://doi.org/10.1101/cshperspect.a022863</ref><ref>https://doi.org/10.1111/j.0013-9580.2004.455003.x</ref>There is little evidence showing there is a concern at medical dosages (600mg and under). This risk may be increased when mixed with other drugs that lower seizure threshold. Caution is recommended when using doses of higher than 600mg. Reducing various susceptibility factors may also be beneficial in lowering this risk. Susceptibility factors may include things such as low sodium, lack of sleep, and intensive physical activity. | ||
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. | It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this substance. |